Xia, Lingfang http://orcid.org/0000-0002-4423-1615
Zhou, Qi http://orcid.org/0000-0001-5673-4263
Gao, Yunong http://orcid.org/0000-0001-9926-0360
Hu, Wenjing
Lou, Ge http://orcid.org/0000-0002-8534-5168
Sun, Hong http://orcid.org/0000-0002-6175-8320
Zhu, Jianqing http://orcid.org/0000-0001-5736-7397
Shu, Jin http://orcid.org/0000-0002-0622-3219
Zhou, Xianfeng http://orcid.org/0000-0001-9382-3310
Sun, Rong http://orcid.org/0000-0001-5541-775X
Wu, Xiaohua http://orcid.org/0000-0002-2271-2514
Funding for this research was provided by:
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Article History
Received: 24 June 2022
Accepted: 17 November 2022
First Online: 8 December 2022
Competing interests
: X.Z. and R.S. report being employed by Jiangsu Hengrui Pharmaceuticals Co., Ltd. The remaining authors declare no other competing interests.